Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%)
Compare proportion of bloodstream infection due to escherichia coli resistant to third-generation cephalosporins (%) across 83 countries or territories using one fixed 2022 WHO reference slice.
Loading visualization...
Key Insights
- •83 ISO-mapped countries or territories have a finite % of bloodstream infections observation in the fixed 2022 slice.
- •Cameroon has the highest published value (96.3 % of bloodstream infections).
- •Finland has the lowest published value (6.67 % of bloodstream infections).
Country Rankings
Top 10 Countries
Bottom 10 Countries
Data Analysis
Value Distribution
How countries are distributed across the value range
Regional Comparison
Average values by world region (Global avg: 45.5% of bloodstream infections)
Percentile Profile
The curve shows how values change from the lowest to the highest country. Steep sections reveal inequality or outliers.
About This Statistic
Proportion of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. E. coli resistant to third generation cephalosporins: E. coli isolates that are resistant as defined by current internationally recognized clinical breakpoints for third generation cephalosporins (e.g., EUCAST or CLSI), specifically ceftriaxone or cefotaxime or ceftazidime.
MapTheory uses only finite ISO-mapped observations from the fixed 2022 WHO slice recorded below. Aggregates, missing values, non-ISO geographies, conflicting duplicate observations, and every other year or dimension slice are excluded; MapTheory never imputes or interpolates missing countries.
Methodology
Proportion of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. E. coli resistant to third generation cephalosporins: E. coli isolates that are resistant as defined by current internationally recognized clinical breakpoints for third generation cephalosporins (e.g., EUCAST or CLSI), specifically ceftriaxone or cefotaxime or ceftazidime.
Full Data
| Rank ↑ | Country ↕ | Value ↕ |
|---|---|---|
| 1 | Cameroon | 96.3% of bloodstream infections |
| 2 | Burkina Faso | 91.7% of bloodstream infections |
| 3 | Myanmar | 90.9% of bloodstream infections |
| 4 | Ghana | 90.4% of bloodstream infections |
| 5 | Yemen | 90.4% of bloodstream infections |
| 6 | Bangladesh | 90.0% of bloodstream infections |
| 7 | Egypt | 87.5% of bloodstream infections |
| 8 | Iraq | 85.7% of bloodstream infections |
| 9 | Pakistan | 83.5% of bloodstream infections |
| 10 | Uganda | 81.8% of bloodstream infections |
| 11 | Ethiopia | 81.0% of bloodstream infections |
| 12 | Syrian Arab Republic | 78.6% of bloodstream infections |
| 13 | Oman | 78.2% of bloodstream infections |
| 14 | India | 77.5% of bloodstream infections |
| 15 | Nepal | 77.1% of bloodstream infections |
| 16 | Peru | 76.7% of bloodstream infections |
| 17 | Zambia | 76.5% of bloodstream infections |
| 18 | Cambodia | 73.5% of bloodstream infections |
| 19 | Benin | 73.1% of bloodstream infections |
| 20 | Democratic Republic of the Congo | 72.6% of bloodstream infections |
| 21 | Moldova, Republic of | 71.9% of bloodstream infections |
| 22 | Islamic Republic of Iran | 70.6% of bloodstream infections |
| 23 | Indonesia | 69.7% of bloodstream infections |
| 24 | United Republic of Tanzania | 68.7% of bloodstream infections |
| 25 | Russian Federation | 64.6% of bloodstream infections |
| 26 | Mozambique | 64.3% of bloodstream infections |
| 27 | Kenya | 63.6% of bloodstream infections |
| 28 | Bahrain | 63.0% of bloodstream infections |
| 29 | Mali | 60.9% of bloodstream infections |
| 30 | Mauritius | 60.4% of bloodstream infections |
| 31 | The Republic of North Macedonia | 60.0% of bloodstream infections |
| 32 | Sri Lanka | 58.8% of bloodstream infections |
| 33 | Jordan | 57.2% of bloodstream infections |
| 34 | Ukraine | 54.6% of bloodstream infections |
| 35 | Saudi Arabia | 52.8% of bloodstream infections |
| 36 | Lao People's Democratic Republic | 52.6% of bloodstream infections |
| 37 | United Arab Emirates | 52.4% of bloodstream infections |
| 38 | Türkiye | 52.2% of bloodstream infections |
| 39 | Timor-Leste | 50.0% of bloodstream infections |
| 40 | Rwanda | 48.0% of bloodstream infections |
| 41 | Georgia | 46.5% of bloodstream infections |
| 42 | Morocco | 46.1% of bloodstream infections |
| 43 | Kuwait | 45.5% of bloodstream infections |
| 44 | Philippines | 43.9% of bloodstream infections |
| 45 | Qatar | 43.3% of bloodstream infections |
| 46 | Cyprus | 40.5% of bloodstream infections |
| 47 | South Korea | 38.8% of bloodstream infections |
| 48 | Lebanon | 37.2% of bloodstream infections |
| 49 | Brazil | 36.3% of bloodstream infections |
| 50 | Thailand | 33.8% of bloodstream infections |
| 51 | South Africa | 30.0% of bloodstream infections |
| 52 | Bosnia and Herzegovina | 26.8% of bloodstream infections |
| 53 | Italy | 26.5% of bloodstream infections |
| 54 | Colombia | 25.6% of bloodstream infections |
| 55 | Singapore | 25.5% of bloodstream infections |
| 56 | Greece | 24.0% of bloodstream infections |
| 57 | Canada | 23.4% of bloodstream infections |
| 58 | Argentina | 22.5% of bloodstream infections |
| 59 | Japan | 20.4% of bloodstream infections |
| 60 | Tunisia | 19.8% of bloodstream infections |
| 61 | Poland | 18.8% of bloodstream infections |
| 62 | Namibia | 18.2% of bloodstream infections |
| 63 | Lithuania | 17.0% of bloodstream infections |
| 64 | Croatia | 16.5% of bloodstream infections |
| 65 | Latvia | 16.2% of bloodstream infections |
| 66 | Brunei Darussalam | 15.6% of bloodstream infections |
| 67 | Czech Republic | 14.5% of bloodstream infections |
| 68 | Malta | 13.4% of bloodstream infections |
| 69 | Australia | 12.7% of bloodstream infections |
| 70 | Estonia | 11.6% of bloodstream infections |
| 71 | United Kingdom | 11.4% of bloodstream infections |
| 72 | Luxembourg | 10.9% of bloodstream infections |
| 73 | Ireland | 10.5% of bloodstream infections |
| 74 | Iceland | 9.8% of bloodstream infections |
| 75 | Switzerland | 9.8% of bloodstream infections |
| 76 | Germany | 9.4% of bloodstream infections |
| 77 | France | 9.1% of bloodstream infections |
| 78 | Belgium | 8.9% of bloodstream infections |
| 79 | Austria | 8.1% of bloodstream infections |
| 80 | Netherlands | 7.6% of bloodstream infections |
| 81 | Denmark | 7.3% of bloodstream infections |
| 82 | Sweden | 7.3% of bloodstream infections |
| 83 | Finland | 6.7% of bloodstream infections |
Topics
Data Source
This data comes from World Health Organization (2022).
View Original Source